Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
11/28/2016 11/29/2016 11/30/2016 12/01/2016 12/02/2016 Date
52(c) 51.5(c) 50.9(c) 51.25(c) 51.15 Last
65 255 125 607 77 799 109 858 115 772 Volume
-0.29% -0.96% -1.17% +0.69% -0.20% Change
More quotes
Financials (€)
Sales 2016 571 M
EBIT 2016 175 M
Net income 2016 115 M
Finance 2016 41,3 M
Yield 2016 1,41%
Sales 2017 644 M
EBIT 2017 200 M
Net income 2017 131 M
Finance 2017 128 M
Yield 2017 1,57%
P/E ratio 2016 24,78
P/E ratio 2017 21,67
EV / Sales2016 4,94x
EV / Sales2017 4,24x
Capitalization 2 862 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
11/02 DIASORIN LAUNCHES ITS FIRST MOLECULA : The new simplexa c. difficile direct mole..
09/09 DIASORIN : acquisition of DiaSorin and Alere brand materials
09/09 DIASORIN : Webinar Showcases Advances in the Diagnosis of Primary Aldosteronism
08/31 ROCHE : Automatic Chemiluminescence Immunoassay Analyzer Market 2016 - Roche, Di..
08/26 DIASORIN : Reagents, controls and consumables for automatic immunoassay analyzer..
08/18 DIASORIN : Webinar Details Parathyroid Hormone Testing in Chronic Kidney Disease..
08/10 DIASORIN : acquisition of DiaSorin and Alere brand materials
08/09 Kyowa Hakko Kirin Announced Kyowa Medex Acquired approval for Insurance Cover..
07/28 DIASORIN : starts selling Vitamin D in Japan
07/27 DIASORIN : Reagents, controls and consumables for automatic immunoassay analyzer..
More news
Sector news : Diagnostic & Testing Substances
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue -- 2nd Update
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Diagnostic & Testing Substances
News from SeekingAlpha
11/18 Winner And Losers Among Italian Companies
11/11 Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides
03/30 DiaSorin buys Quest's diagnostic products business for $300M
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 57,5 €
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA5.06%3 051
BIOMERIEUX18.70%5 468
SICHUAN MAKER BIOTECHN..--.--%2 106
GUANGZHOU WONDFO BIOTE..--.--%1 851
SHANGHAI KEHUA BIO-ENG..--.--%1 683
NINGBO MEDICALSYSTEM B..--.--%1 667
More Results